3 ms·

> ...once you've amassed a certain amount of capital, which you can then expend to defend your enterprise from any number of legal challenges I wonder if that'

> ...once you've amassed a certain amount of capital, which you can then expend to defend your enterprise from any number of legal challenges I wonder if that's part of the Silicon Valley secret sauce - there seems to be a gentleman's agreement not to sue startups. > So why don't we have two dozen scrappy American firms competing against Pfizer's Meridian Medical Technologies to produce adrenaline auto-injectors? The FDA approved the first generic auto-injector in 2018.

quacked 2y ago
> The FDA approved the first generic auto-injector in 2018. Sure, but the length of the time it took, plus the lack of any pressure on the price of name-brand EpiPens, is a huge problem, in my view. The legal barriers to market entry should be exclusively technical (i.e. can you prove that your process meets consequential technical standards), and right now they're quite removed from that.